These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 23652942

  • 1. Periungual pyogenic granuloma following imatinib therapy in a patient with chronic myelogenous leukemia.
    Dika E, Barisani A, Vaccari S, Fanti PA, Ismaili A, Patrizi A.
    J Drugs Dermatol; 2013 May; 12(5):512-3. PubMed ID: 23652942
    [No Abstract] [Full Text] [Related]

  • 2. Imatinib-induced nail hyperpigmentation in chronic myeloid leukemia.
    Prabhash K, Biswas G, Prasad N, Karant N, Sastry PS, Parikh PM.
    Indian J Dermatol Venereol Leprol; 2006 May; 72(1):63-4. PubMed ID: 16481719
    [No Abstract] [Full Text] [Related]

  • 3. Trachyonychia in a patient with chronic myeloid leukaemia after imatinib mesylate.
    Lau YM, Lam YK, Leung KH, Lin SY.
    Hong Kong Med J; 2014 Oct; 20(5):464.e2. PubMed ID: 25307080
    [No Abstract] [Full Text] [Related]

  • 4. Vocal fold hemorrhage in a CML patient after Glivec treatment.
    Shim HS, Woo SH.
    Acta Oncol; 2013 May; 52(4):866-8. PubMed ID: 23153030
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oral mucosal hyperpigmentation and horizontal melanonychia caused by imatinib.
    Steele JC, Triantafyllou A, Rajlawat BP, Field EA.
    Clin Exp Dermatol; 2012 Jun; 37(4):432-3. PubMed ID: 22420895
    [No Abstract] [Full Text] [Related]

  • 10. Hyperpigmentation of the hard palate associated with imatinib therapy for chronic myeloid leukemia with a genetic variation in the proto-oncogene c-KIT.
    Khoo TL, Catalano A, Supple S, Chong L, Yeoh SC, Yeung S, Iland H.
    Leuk Lymphoma; 2013 Jan; 54(1):186-8. PubMed ID: 22712835
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Imatinib: a designer drug, another cutaneous complication.
    Dickens E, Lewis F, Bienz N.
    Clin Exp Dermatol; 2009 Jul; 34(5):603-4. PubMed ID: 19486036
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pseudoporphyria induced by imatinib mesylate.
    Pérez NO, Esturo SV, Viladomiu Edel A, Moreno AJ, Valls AT.
    Int J Dermatol; 2014 Feb; 53(2):e143-4. PubMed ID: 23451912
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Psoriasis vulgaris exacerbated by imatinib therapy in chronic myelogenous leukemia].
    Shimizu K, Kuroda H, Kida M, Watanabe H, Shirao S, Akiyama T, Fujimi A, Tanaka I, Sato T, Matsunaga T, Niitsu Y.
    Rinsho Ketsueki; 2005 Oct; 46(10):1152-5. PubMed ID: 16440780
    [Abstract] [Full Text] [Related]

  • 19. [Chronic myeloid leukemia treatment and human immunodeficiency virus infection].
    Campillo-Recio D, Perez-Rodriguez L, Yebra E, Cervero-Jimenez M.
    Rev Clin Esp (Barc); 2014 May; 214(4):231-2. PubMed ID: 24564991
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.